Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 477.06 KB
Add to list
  1. Search results
  2. Ablative intravesical chemotherapy fo...

Ablative intravesical chemotherapy for small recurrent non-muscle-invasive bladder cancer : a prospective study

Karel Decaestecker (UGent) , Nicolaas Lumen (UGent) , Annelies Ringoir and Willem Oosterlinck (UGent)
(2016) UROLOGIA INTERNATIONALIS. 96(1). p.14-19
Author
Organization
Keywords
urothelial bladder neoplasm, intravesical chemotherapy, epirubicin, chemoresection, mitomycin C, TRANSURETHRAL RESECTION, PHASE-II, TUMORS, CHEMORESECTION, CARCINOMA, SCHEDULE, THERAPY, TRIALS, STAGE

Downloads

  • Download
    (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 477.06 KB

Citation

Please use this url to cite or link to this publication:

MLA
Decaestecker, Karel, et al. “Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer : A Prospective Study.” UROLOGIA INTERNATIONALIS, vol. 96, no. 1, 2016, pp. 14–19, doi:10.1159/000377639.
APA
Decaestecker, K., Lumen, N., Ringoir, A., & Oosterlinck, W. (2016). Ablative intravesical chemotherapy for small recurrent non-muscle-invasive bladder cancer : a prospective study. UROLOGIA INTERNATIONALIS, 96(1), 14–19. https://doi.org/10.1159/000377639
Chicago author-date
Decaestecker, Karel, Nicolaas Lumen, Annelies Ringoir, and Willem Oosterlinck. 2016. “Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer : A Prospective Study.” UROLOGIA INTERNATIONALIS 96 (1): 14–19. https://doi.org/10.1159/000377639.
Chicago author-date (all authors)
Decaestecker, Karel, Nicolaas Lumen, Annelies Ringoir, and Willem Oosterlinck. 2016. “Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer : A Prospective Study.” UROLOGIA INTERNATIONALIS 96 (1): 14–19. doi:10.1159/000377639.
Vancouver
1.
Decaestecker K, Lumen N, Ringoir A, Oosterlinck W. Ablative intravesical chemotherapy for small recurrent non-muscle-invasive bladder cancer : a prospective study. UROLOGIA INTERNATIONALIS. 2016;96(1):14–9.
IEEE
[1]
K. Decaestecker, N. Lumen, A. Ringoir, and W. Oosterlinck, “Ablative intravesical chemotherapy for small recurrent non-muscle-invasive bladder cancer : a prospective study,” UROLOGIA INTERNATIONALIS, vol. 96, no. 1, pp. 14–19, 2016.
@article{6862819,
  author       = {{Decaestecker, Karel and Lumen, Nicolaas and Ringoir, Annelies and Oosterlinck, Willem}},
  issn         = {{0042-1138}},
  journal      = {{UROLOGIA INTERNATIONALIS}},
  keywords     = {{urothelial bladder neoplasm,intravesical chemotherapy,epirubicin,chemoresection,mitomycin C,TRANSURETHRAL RESECTION,PHASE-II,TUMORS,CHEMORESECTION,CARCINOMA,SCHEDULE,THERAPY,TRIALS,STAGE}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{14--19}},
  title        = {{Ablative intravesical chemotherapy for small recurrent non-muscle-invasive bladder cancer : a prospective study}},
  url          = {{http://doi.org/10.1159/000377639}},
  volume       = {{96}},
  year         = {{2016}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: